The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors

A recent study suggested that proton pump inhibitor (PPI) use in patients with advanced non-small-cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICIs) was associated with poor clinical outcomes. However, the clinical impact of PPI use on the outcome of patients receiving ICIs for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Kazuki, Shimokawa, Mototsugu, Takamori, Shinkichi, Shimamatsu, Shinichiro, Hirai, Fumihiko, Ono, Yuki, Tagawa, Tetsuzo, Okamoto, Tatsuro, Hamatake, Motoharu, Okamoto, Isamu, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820612/
https://www.ncbi.nlm.nih.gov/pubmed/35130287
http://dx.doi.org/10.1371/journal.pone.0263247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820612/
https://www.ncbi.nlm.nih.gov/pubmed/35130287
http://dx.doi.org/10.1371/journal.pone.0263247

Ejemplares similares